Wiley

APLAR Journal of Rheumatology Template

Write in a clean editor, then format for APLAR Journal of Rheumatology in one click — DocuGuru applies the official Wiley template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.

About the APLAR Journal of Rheumatology format

APLAR Journal of Rheumatology is a peer-reviewed journal published by Wiley, covering Systemic Lupus Erythematosus Research, Rheumatoid Arthritis Research and Therapies, Autoimmune and Inflammatory Disorders Research.

PublisherWiley
Reference styleAuthor–year (Chicago)
Author–year — (Smith, 2023) in the text
Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." APLAR Journal of Rheumatology 12 (3): 45–58.

Formats any DOI in APLAR Journal of Rheumatology style. No sign-up.

Publishes research inSystemic Lupus Erythematosus Research Rheumatoid Arthritis Research and Therapies Autoimmune and Inflammatory Disorders Research Spondyloarthritis Studies and Treatments Musculoskeletal Disorders and Rehabilitation
ISSN0219-0494
h-index21
i10-index50
Total citations2,271
Top institutions publishing hereCenter for Rheumatology
You getA submission-ready PDF and the editable LaTeX source — ready to submit.

Papers published in APLAR Journal of Rheumatology per year

1
1994
1
1998
2
1999
29
2002
43
2003
58
2004
50
2005
134
2006
87
2007
1
2010

Citation impact of APLAR Journal of Rheumatology by publication year

0
1994
0
1998
1
1999
42
2002
130
2003
246
2004
262
2005
984
2006
590
2007
7
2010

Citations each year’s papers have accumulated so far — the most recent years are still building up.

Most-cited papers in APLAR Journal of Rheumatology

Role of tumor necrosis factor‐alpha in rheumatoid arthritis: a review

Vasanthi Pallinti, Nalini Ganesan, G Rajasekhar · 1 Dec 2007

Abstract Tumor necrosis factor‐alpha (TNF‐α) is a proinflammatory cytokine that plays a pivotal role in regulating the inflammatory response in rheumatoid arthritis (RA). Although it is controversial whether TNF‐α genes are associated with RA susceptibility, they are well known to mediate RA pathogenesis. We review in depth the history, formation and biological action, TNF receptor,…

A randomized, double‐blind, placebo‐controlled, phase III study of the human anti‐tumor necrosis factor antibody adalimumab administered as subcutaneous injections in Korean rheumatoid arthritis patients treated with methotrexate

Ho‐Youn Kim, Soo‐Kon LEE, Yeong Wook Song et al. · 8 Mar 2007

Abstract Objective: Adalimumab is a fully human, monoclonal, antitumour necrosis factor antibody approved for the treatment of rheumatoid arthritis (RA) in more than 60 countries. We investigated the efficacy and safety of 40 mg every‐other‐week (eow) subcutaneous injections of adalimumab with methotrexate (MTX) versus placebo with MTX in Korean patients with RA with insufficient responses…

The incidence of hip fracture in Malaysians above 50 years of age: variation in different ethnic groups

J. K. Lee, Amir Sharifuddin Md Khir · 1 Dec 2007

Abstract Aims: Hip fracture is frequently studied to reflect osteoporosis related fractures. The aim of this study was to look at ethnic differences in the incidence of hip fractures between the three races in Malaysia. Methods: This was a retrospective study performed for the years 1996 and 1997. Data from hospitals treating hip fractures in…

Infliximab versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a preliminary study from China

Feng‐Chun Zhang, Yong Hou, Feng Huang et al. · 12 Jul 2006

Abstract Aim: To report the efficacy and safety of infliximab in the treatment of active rheumatoid arthritis (RA) in Chinese patients. Methods: This is a multicentre double‐blind placebo controlled study. Patients with active RA despite being on a stable dose of methotrexate were randomly assigned to receive either infliximab 3 mg/kg body weight or placebo…

APLAR Journal of Rheumatology template — frequently asked questions

How do I write a paper in the APLAR Journal of Rheumatology format?
In DocuGuru you write your manuscript in a normal editor — no LaTeX setup required — and select the APLAR Journal of Rheumatology template. When you export, DocuGuru compiles the paper into the official Wiley format and hands you a submission-ready PDF along with the editable LaTeX source.
What reference style does APLAR Journal of Rheumatology use?
APLAR Journal of Rheumatology uses Author–year (Chicago) references, shown as author–year markers such as (Smith, 2023) in the text. DocuGuru formats every in-text citation and the reference list in this exact style automatically. A reference appears like this: Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." APLAR Journal of Rheumatology 12 (3): 45–58.
Do I need to know LaTeX to submit to APLAR Journal of Rheumatology?
No. DocuGuru generates the USG LaTeX class and compiles the PDF for you in the background, so you get a Wiley-ready APLAR Journal of Rheumatology document without writing any LaTeX. If you do want it, the LaTeX source is included in the export.
Can I import an existing draft into the APLAR Journal of Rheumatology template?
Yes. Paste or upload your current manuscript — Word, LaTeX, Markdown, or plain text — and DocuGuru reflows it into the APLAR Journal of Rheumatology format with correct headings, figures, tables, and author–year citations.
Who publishes APLAR Journal of Rheumatology?
APLAR Journal of Rheumatology is a multidisciplinary journal published by Wiley. DocuGuru's APLAR Journal of Rheumatology template matches Wiley's official submission format.
Can I export a submission-ready APLAR Journal of Rheumatology PDF?
Yes — DocuGuru produces a PDF built with the official APLAR Journal of Rheumatology template (the USG class) that is ready to submit to Wiley, together with the matching LaTeX source files.
How much does the APLAR Journal of Rheumatology template cost?
You can start writing in the APLAR Journal of Rheumatology template for free. Exporting the final submission-ready APLAR Journal of Rheumatology PDF and LaTeX source is part of DocuGuru's paid plans — see the app for current pricing.
Use the APLAR Journal of Rheumatology template